This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Mallal S, Phillips E, Carosi G, Molina J-M, Workman C, Tomažič J, Jägel-Guedes E, Rugina S, Kozyrev O, Flores J, Hay P, Nolan D, Hughes S, Hughes A, Ryan S, Fitch N, Thorborn D, Benbow A, PREDICT-1 Study Team.HLA-B*5701 screening for hypersensitivity to abacavir. New England Journal of Medicine 358: 568-579, No. 6, 7 Feb 2008
Ingelman-Sundberg M.Pharmacogenomic biomarkers for prediction of severe adverse drug reactions. New England Journal of Medicine 358: 637-639, No. 6, 7 Feb 2008
Rights and permissions
About this article
Cite this article
Pharmacogenetic screening avoids abacavir hypersensitivity reaction. React. Wkly. 1189, 6 (2008). https://doi.org/10.2165/00128415-200811890-00019
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-200811890-00019